The Effects of Gait Rehabilitation After Stroke by Treadmill-based Robotics Versus Traditional Gait Training

NCT03688165 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2025-04-02

No results posted yet for this study

Summary

This multicenter non-randomized controlled trial aims to investigate the effectiveness (an increase of the walking speed in the 10 Meter Walk Test - 10MWT) of the robotic treatment with exoskeleton or end-effector system compared to the conventional rehabilitative treatment for the gait recovery after stroke, and to compare the possible different efficacy of end-effector and exoskeleton systems in the various post-stroke disability frameworks.

All the eligible subjects admitted to rehabilitation centers, both in the subacute phase will be recorded. The experimental group will follow a set of robotic gait training on stationary robotic systems which do not provide overground gait training (Lokomat Pro - Hocoma AG, Volketswil, Switzerland; G-EO System - Reha technologies, Italy). While, the control group will follow traditional gait training composed of all those exercises which promote the recovery of walking ability (please, see the details of the interventions).

Conditions

  • Stroke
  • Acute Stroke
  • Chronic Stroke

Interventions

DEVICE

Treadmill-based Robotic Gait Training

All the stroke survivors admitted to the participating centers and eligible for the study will follow a gait training protocol (treadmill-based or overground). The data will be registered at baseline (T0), end of treatment (T1) and at three months follow up (T2). All robotic systems used for the study (Lokomat Pro - Hocoma AG, Volketswil, Switzerland); G-EO System - Reha technologies, Italy) are treadmill-based and do not provide the over-ground gait training. They are characterized by the possibility of a programmable weight support, as well as speed and stride length. The data relating to the patients' training is always displayed and stored with a computerized control system.

OTHER

Traditional Over-ground Gait Training

Traditional treatment for gait training consists in any conventional technical approach aimed at achieving control of the postural passages from sitting upright, of load transfer in laterality and antero-posterior in orthostatism and reorganization of the step up to the assisted path to the parallels and then with various aids.

Sponsors & Collaborators

  • Ospedale Santo Stefano

    collaborator OTHER
  • APSS Trento

    collaborator UNKNOWN
  • Azienda Sanitaria n. 4 Chiavarese

    collaborator OTHER
  • Fondazione Don Carlo Gnocchi Onlus

    collaborator OTHER
  • Azienda Ospedaliera San Gerardo di Monza

    collaborator OTHER
  • University Hospital of Ferrara

    collaborator OTHER
  • Privatklinik Villa Melitta

    collaborator OTHER
  • Centro Ricerche Cliniche di Verona

    collaborator OTHER
  • Unità di Neuroriabilitazione, HABILITA

    collaborator UNKNOWN
  • Istituto Piero Redaelli, Milano

    collaborator UNKNOWN
  • S. Anna Hospital

    collaborator OTHER
  • Azienda Sanitaria Locale n.2 Savonese

    collaborator OTHER
  • Fondazione Centri di Riabilitazione Padre Pio Onlus

    collaborator UNKNOWN
  • Habilita, Ospedale di Sarnico

    collaborator OTHER
  • I.R.C.C.S. Fondazione Santa Lucia

    collaborator OTHER
  • Azienda Ospedaliero, Universitaria Pisana

    collaborator OTHER
  • Azienda Socio Sanitaria Territoriale di Mantova

    collaborator OTHER
  • IRCCS San Raffaele Roma

    lead OTHER

Principal Investigators

  • Marco Franceschini, MD · IRCCS San Raffaele Pisana

  • Sanaz Pournajaf, Dr · IRCCS San Raffaele Pisana

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2022-06-30
Completion
2022-07-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03688165 on ClinicalTrials.gov